HHS Office of Inspector General says Illinois should reduce Medicaid rates for diabetes test strips, and that Medicare is paying so-called G modifier claims inappropriately in reports last week. More reimbursement news.
CMS on May 9 posted reimbursement rates for 114 new molecular diagnostic codes established by local Medicare contractors using the clinical lab fee schedule gap-filling method. (http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Gapfill-Pricing-Inquiries.html
). Labs developing and running molecular diagnostics have complained that the price-setting process has been unfair and overly opaque. (See Also see "Molecular Dx Labs Fret Over Medicare Payment...
Predictability, proportionality, stability, harmonization and simplification offer the right way forward to address the challenging unintended effects of the EU medical device regulations, the European Commission’s head of devices tells the EU’s largest annual medtech conference.
German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.
Medtronic expects operating profit to grow approximately 7% in fiscal 2026, excluding tariff impacts. If tariffs materialize at the upper end of the projected range, operating profit growth could drop by 2.2 to 3.2 percentage points.
